Table 1: Demographic and treatment data on 34 patients with PMCA from appendix cancer who received neoadjuvant systemic chemotherapy prior to cytoreductive surgery and HIPEC. None of these clinical parameters were predictive of histological response.

Patients treated with neoadjuvant chemotherapyPatients not treated with neoadjuvant chemotherapy value

Age (mean)47.948.80.66
Gender0.53
 Male1710
 Female1714
Histological subtype0.37
 Signet ring94
 PMCA/adenocarcinoid2520
Lymph node status0.62
 Positive127
 Negative2217
Number of preoperative chemotherapy cyclesN/A
 6 cycles12
 12 cycles22
Chemotherapy regimensN/A
 FOLFOX30
 XELOX4
Use of bevacizumabN/A
 Yes21
 No13
Gross assessment of response at cytoreductionN/A
 Stable or response16
 Progression17
Histological assessment of response
 No response24
 Complete or near-complete response10